Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:02:05 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Q:XRTX - XORTX THERAPEUTICS INC - https://www.xortx.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
XRTX - Q0.10.3567·0.451.70.4004-0.0028-0.7153.2374110.3858  0.43  0.3821.41  0.403219:43:50Feb 0415 min RT 2¢

Recent Trades - Last 10 of 411
Time ETExPriceChangeVolume
19:43:50Q0.39-0.013247
19:43:40Q0.39-0.013294
19:07:27Q0.39-0.01321,052
18:46:09Q0.3819-0.0213580
18:46:08Q0.3819-0.0213400
18:46:08Q0.3819-0.0213702
18:15:18Q0.394-0.009296
18:14:51Q0.396-0.00724
18:08:17Q0.396-0.00726
18:07:49Q0.3959-0.00735

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-04 18:00U:XRTXNews ReleaseXORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
2025-12-31 18:15U:XRTXNews ReleaseXORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
2025-10-29 07:00U:XRTXNews ReleaseXORTX Announces Closing of US$1.1 Million Registered Direct Offering
2025-10-21 08:00U:XRTXNews ReleaseXORTX Announces Pricing of US$1.1 Million Registered Direct Offering
2025-10-20 20:35U:XRTXNews ReleaseXORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
2025-10-20 18:45U:XRTXNews ReleaseXORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
2025-10-17 07:00U:XRTXNews ReleaseXORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
2025-09-04 07:00U:XRTXNews ReleaseJoin XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10
2025-09-03 07:00U:XRTXNews ReleaseXORTX Initiates IND Preparation for XORLO(TM) in Gout Program
2025-08-08 19:55U:XRTXNews ReleaseXORTX Completes USD $114,500 Private Placement
2025-08-07 07:00U:XRTXNews ReleaseXORTX Provides Corporate Update and Planned Activities for 2025 / 2026
2025-07-31 07:00U:XRTXNews ReleaseXORTX Announces USD $114,500 Private Placement
2025-07-22 19:59U:XRTXNews ReleaseXORTX Completes Non-Brokered Private Placement of Units
2025-06-26 07:00U:XRTXNews ReleaseXORTX Announces USD $925,000 Private Placement
2025-05-19 07:00U:XRTXNews ReleaseXORTX Announces USD $3 Million Offering
2025-04-30 07:00U:XRTXNews ReleaseXORTX Provides Update on FDA Type B Meeting Request
2025-04-28 07:00U:XRTXNews ReleaseXORTX Announces Grant of European Patent
2025-04-17 19:45U:XRTXNews ReleaseXORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
2025-03-19 07:00U:XRTXNews ReleaseXORTX Announces Update for Discussion with the FDA
2025-02-24 07:00U:XRTXNews ReleaseXORTX Commences Gout Program NDA Discussions with the FDA